Oral cancer susceptibility associated with the CYP1A1 and GSTM1 genotypes in Chilean individuals

Oncology Letters

Volumn 1, Issue 3, 2010, Pages 549-553

  Cordero, Karina ^a   Espinoza, Iris ^b   Caceres, Dante ^a   Roco, Angela ^a,c   Miranda, Carla ^a,c   Squicciarini, Valentina ^a   Santander, Paula ^a   Lee, Kuen ^a   Saavedra, Iván ^a   Quiñones, Luis ^a  

^a UNIVERSITY OF CHILE   (Chile)

^b Department of Oral Pathology   (Chile)

^c HOSPITAL SAN JUAN DE DIOS   (Chile)

Author keywords

CYP1A1; Genotype; GSTM1; Oral cancer; Polymorphisms

Indexed keywords

CYTOCHROME P450 1A; DNA; GLUTATHIONE TRANSFERASE M1;

ADULT; ALLELE; ARTICLE; CANCER SUSCEPTIBILITY; CHILE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; MALE; MOUTH CANCER; POLYMERASE CHAIN REACTION; RACE DIFFERENCE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SMOKING; WILD TYPE;

EID: 77955754790     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol_00000097     Document Type: Article

References (37)

1. Shimada T: Xenobiotic-metabolizing enzymes involved in activation and detoxification of carcinogenic polycyclic aromatic hydrocarbons. Drug Metab Pharmacokinet 21: 257-276, 2006.
2. Elovaara E, Mikkola J, Stockmann-Juvala H, Luukkanen L, Keski-Hynnilä H, Kostiainen R, Pasanen M, Pelkonen O and Vainio H: Polycyclic aromatic hydrocarbon (PAH) metabolizing enzyme activities in human lung, and their inducibility by exposure to naphthalene, phenanthrene, pyrene, chrysene, and benzo(a)pyrene as shown in the rat lung and liver. Arch Toxicol 81: 169-182, 2007.
3. Agúndez JA: Cytochrome P450 gene polymorphism and cancer. Curr Drug Metab 5: 211-224, 2004.
4. Shimada T and Fijii-Kuriyama Y: Metabolic activation of polycyclic aromatic hydrocarbons to carcinogens by cytochromes P450 1A1 and 1B1. Cancer Sci 95: 1-6, 2004.
5. Wright CM, Larsen JE, Colosimo ML, Barr JJ, Chen L, McLachlan RE, Yang IA, Bowman RV and Fong KM: Genetic association study of CYP1A1 polymorphisms identifies risk haplotypes in non-small cell lung cancer. Eur Respir J 35: 152-159, 2010.
6. Yang XR, Wacholder S, Xu Z, Dean M, Clark V, Gold B, Brown LM, Stone BJ, Fraumeni JF and Caporaso NE: CYP1A1 and GSTM1 polymorphisms in relation to lung cancer risk in Chinese women. Cancer Lett 214: 197-204, 2004.
7. Sreeja L, Syamala V, Hariharan S, Madhavan J, Devan SC and Ankathil R: Possible risk modification by CYP1A1, GSTM1 and GSTT1 gene polymorphisms in lung cancer susceptibility in a south Indian population. J Hum Genet 50: 618-627, 2005.
8. Cha IH, Park JY, Chung WY, Choi MA, Kim HJ and Park KK: Polymorphisms of CYP1A1 and GSTM1 genes and susceptibility to oral cancer. Yonsei Med J 48: 233-239, 2007.
9. Anantharaman D, Chaubal PM, Kannan S, Bhisey RA and Mahimkar MB: Susceptibility to oral cancer by genetic polymorphisms at CYP1A1, GSTM1 and GSTT1 loci among Indians: tobacco exposure as a risk modulator. Carcinogenesis 28: 1455-1462, 2007.
10. Chatarjee S, Chakrabarti S, Sengupta B, Poddar S, Biswas D, Sengupta S and Taludker G: Prevalence of CYP1A1 and GST polymorphisms in the population of northeastern India and susceptibility of oral cancer. Oncol Res 17: 397-403, 2009.
11. Acevedo C, Opazo JL, Huidobro C, Cabezas J, Iturrieta J and Quiñones L: Positive correlation between single or combined genotypes of CYP1A1 and GSTM1 in relation to prostate cancer in Chilean people. Prostate 57: 111-117, 2003.
12. Little J, Sharp L, Masson LF, Brockton N, Cotton S, Haites N and Cassidy J: Colorectal cancer and genetic polymorphisms of CYP1A1, GSTM1 and GSTT1: a case-control study in the Grampian region of Scotland. Int J Cancer 119: 2155-2164, 2006.
13. Lee K, Cáceres D, Varela N, Csendes A, Ríos H and Quiñones L: Evaluation of CYP1A1 and GSTM1 as gastric cancer susceptibility biomarkers: influence of smoking habit and alcohol consumption. Rev Med Chil 134: 1107-1115, 2006.
14. Kiss I, Orsós Z, Gombos K, Bogner B, Csejtei A, Tibold A, Varga Z, Pázsit E, Magda I, Zölyomi A and Ember I: Association between allelic polymorphisms of metabolizing enzymes (CYP 1A1, CYP 1A2, CYP 2E1, mEH) and occurrence of colorectal cancer in Hungary. Anticancer Res 27: 2931-2937, 2007.
15. Quiñones L and Gil L: Induction of rat hepatic cytochrome P450 1A1 isozyme by organic extracts from airborne particulate matter. Xenobiotica 25: 571-579, 1995.
16. Kawajiri K, Watanabe J, Gotoh O, Tagashira Y, Sowaga K and Fujii-Kuriyama Y: Structure and drug inducibility of human cytochrome P450c gene. Eur J Biochem 159: 219-225, 1986.
17. Kawajiri K, Nakachi K, Imai A, Yoshu N, Shimada J and Watanabe J: Identification of genetically high risk individuals to oral cancer by DNA polymorphisms of the cytochrome P4501A1 gene. FEBS Lett 263: 131-133, 1990.
18. Hayashi S, Watanabe J, Nakachi K and Kawajiri K: PCR detection of an A/G polymorphism within exon 7 of the CYP1A1 gene. Nucleic Acids Res 19: 4797, 1991.
19. Crofts F, Cosma G, Currie D, Taioli E, Toniolo P and Garte S: A novel, CYP1A1 gene polymorphism in African-Americans. Carcinogenesis 14: 29-31, 1993.
20. Cascorbi L, Brockmoller J and Roots L: A C4887A polymorphism in exon 7 of human CYP1A1: population frequency, mutation linkages and impact on oral cancer susceptibility. Cancer Res 56: 4965-4969, 1996.
21. Aynacioglu A, Cascorbi I, Ozikiewicz P and Roots I: High frequency of CYP1A1 mutations in a Turkish population. Arch Toxicol 72: 215-218, 1998.
22. Magno LA, Talbot J, Talbot T, Borges Santos AM, Souza RP, Marin LJ, Moreli ML, de Melo PR, Corrêa RX, Rios Santos F and Di Pietro G: Glutathione s-transferase variants in a brazilian population. Pharmacology 83: 231-236, 2009.
23. Bailliet G, Santos MR, Alfaro EL, Dipierri JE, Demarchi DA, Carnese FR and Bianchi NO: Allele and genotype frequencies of metabolic genes in Native Americans from Argentina and Paraguay. Mutat Res 627: 171-177, 2007.
24. Torres MM, Acosta CP, Sicard DM and Groot de Restrepo H: Genetic susceptibility and risk of gastric cancer in a human population of Cauca, Colombia. Biomedica 24: 153-162, 2004.
25. Quiñones L, Berthou F, Varela N, Simon B, Gil L and Lucas D: Ethnic susceptibility to lung cancer: differences in CYP2E1, CYP1A1 and GSTM1 genetic polymorphisms between French Caucasian and Chilean populations. Cancer Lett 141: 167-171, 1999.
26. Seidegard J, Vorachek W, Pero R and Pearson W: Hereditary differences in the expression of the human glutathione transferase active on trans-stilbene oxide are due to a gene deletion. Proc Natl Acad Sci USA 85: 7293-7297, 1998.
27. Lin H-J, Han C-Y, Bernstein DA, Hsiao W, Lin B and Hardy S: Ethnic distribution of the glutathione transferase Mu 1-1 (GSTM1) null genotype in 1473 individuals and application to bladder cancer susceptibility. Carcinogenesis 15: 1077-1081, 1994.
28. Linhares JJ, Da Silva ID, De Souza NC, Noronha EC, Ferraro O, De Carvallo CV and Bacarat FF: Genetic polymorphism of GSTM1 in women with breast cancer and interact with reproductive history and several clinical pathologies. Biol Res 38: 273-281, 2005.
29. Boccia S, Sayed-Tabatabaei FA, Persiani R, Gianfagna F, Rausei S, Arzani D, La Greca A, D'Ugo D, La Torre G, van Duijn CM and Ricciardi G: Polymorphisms in metabolic genes, their combination and interaction with tobacco smoke and alcohol consumption and risk of gastric cancer: a case-control study in an Italian population. BMC Cancer 7: 206, 2007.
30. Quiñones L, Lucas D, Godoy J, Cáceres D, Berthou F, Varela N, Lee K, Acevedo C, Martínez L, Aguilera AM and Gil L: CYP1A1, CYP2E1 and GSTM1 genetic polymorphisms. The effect of single and combined genotypes on lung cancer susceptibility in chilean people. Cancer Lett 174: 35-44, 2001.
31. Lira MG, Provezza L, Malerba G, Naldi L, Remuzzi G, Boschiero L, Forni A, Rugiu C, Piaserico S, Alaibac M, Turco A, Girolomoni G and Tessari G: Glutathione S-transferase and CYP1A1 gene polymorphisms and non-melanoma skin cancer risk in Italian transplanted patients. Exp Dermatol 15: 958-965, 2006.
32. Yoshida K, Osawa K, Kasahara M, Miyaishi A, Nakanishi K, Hayamizu S, Osawa Y, Tsutou A, Tabuchi Y, Shimada E, Tanaka K, Yamamoto M and Takahashi J: Association of CYP1A1, CYP1A2, GSTM1 and NAT2 gene polymorphisms with colorectal cancer and smoking. Asian Pac J Cancer Prev 8: 438-444, 2007.
33. Caceres D, Iturrieta J, Acevedo C, Huidobro C, Varela N and Quiñones L: Relationship among metabolizing genes, smoking and alcohol use as modifier factors on prostate cancer risk: Exploring some gene-gene and gene-environment interactions. Eur J Epidemiol 20: 79-88, 2005.
34. Das BR and Nagpal JK: Understanding the biology of oral cancer. Med Sci Monit 8: RA258-RA267, 2002.
35. Riera P and Martínez B: Morbidity and mortality for oral and pharyngeal cancer in Chile. Rev Med Chil 133: 555-563, 2005.
36. Ambrosone C, Freudenheim J, Oraham S, Marshall J, Vena J, Brasure J, Laughlin R, Nemoto T, Michalek A, Harrington A, Ford T and Shields P: Cytochrome P4501A1 and glutathione S-transferase (Ml) genetic polymorphisms and postmenopausal breast cancer risk. Cancer Res 55: 3483-3485, 1995.
37. Garte S: The role of ethnicity in cancer susceptibility gene polymorphisms: the example of CYP1A1. Carcinogenesis 19: 1329-1332, 1998.